Michael de Veer
Monash University Facility Fellow
Dr de Veer obtained his PhD in Biochemistry at Monash University and has extensive post-doctoral experience in signalling pathways, linking tracers and mapping cell migration and immune modulation within the lymphatic system. A large portion of his research is conducted with industry partners and he understands the interface between academic and translational research. He is currently leading the pre-clinical imaging team at Monash Biomedical Imaging and brings extensive experience with the large animal and rodent models that our users want to image. His own imaging research is aimed at developing MR and PET-MR imaging agents to delineate the lymphatic system in pre-clinical models of oedema and disease. He is an advocate for the benefits and impact of incorporating multi-modal imaging into projects to produce excellent research outcomes. A large part of his role is to facilitate industry engagement with the facility and drive translational research.
Related News
New molecular-imaging network launched to benefit cancer, dementia imaging and new radiopharmaceuticals
A new national-scale molecular-imaging network that aims to improve cancer imaging, dementia diagnosis and treatment, and new radiopharmaceuticals was launched Saturday at the annual meeting for Austr
26 May 2025
ACRF awards include $12 million funding toward NIF-supported national total-body PET/CT network to advance cancer research
The Governor-General, Her Excellency the Honourable Sam Mostyn AC has announced the award of Australian Cancer Research Foundation’s (ACRF) 2024 grants at Government House in Canberra. The announcem
25 November 2024
Curtin Media: Updated concussion app to help improve recovery and guide future research
The groundbreaking Australian Mild Traumatic Brain Injury (AUS-mTBI) study will see thousands of volunteers from across the country who have had a recent concussion have the option to opt-in to repo
01 August 2024
COSMOS: Clearer and faster: 5-minute MRI on the horizon
16 March 2024
Related Capabilities
Related Publications
In vivo biomarkers of GABAergic function in epileptic rats treated with the GAT-1 inhibitor E2730
Idrish Ali, Bianca Jupp, Matthew R. Hudson, Brendan Major, Juliana Silva, Glenn R. Yamakawa, Pablo M. Casillas-Espinosa, Emma Braine, Peravina Thergarajan, Mohammad B. Haskali, Lucy Vivash, Robert Brkljaca, Sandy R. Shultz, Patrick Kwan, Kazuyuki Fukushima, Pallavi Sachdev, Jocelyn Y. Cheng, Richelle Mychasiuk, Nigel C. Jones, David K. Wright, Terence J. OBrien
Read Publication
Experimental assessment of diffusible iodine-based contrast-enhanced computed tomography (diceCT) protocols
Lucy F. Costello, Hazel L. Richards, Alistair R. Evans, Justin W. Adams
Read Publication
PERS: Parameter-Efficient Multimodal Transfer Learning for Remote Sensing Visual Question Answering
Jinlong He, Gang Liu, Pengfei Li, Xiaonan Su, Wenhua Jiang, Dongze Zhang, Shenjun Zhong
Read Publication
Novel formylpeptide receptor 1/2 agonist limits hypertension-induced cardiovascular damage
Jaideep Singh, Kristy L Jackson, Haoyun Fang, Audrey Gumanti, Bethany Claridge, Feng Shii Tang, Helen Kiriazis, Ekaterina Salimova, Alex M Parker, Cameron Nowell, Owen L Woodman, David W Greening, Rebecca H Ritchie, Geoffrey A Head, Cheng Xue Qin
Read Publication